Wound closure in orthopaedic surgery Surgery Wound closure
Conditions
Interventions
A prospective randomised controlled pilot study. Patients will be randomised to:
1. Tissue adhesive (Dermabond)
2. Standard wound closure
Sponsors
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who are more than 1 year old and less than 16 2. Undergoing elective orthopaedic procedures 3. In good health and without significant abnormalities 4. Agreeing to return for follow-up at 10 days, 6 weeks and 6 months
Exclusion criteria
Exclusion criteria: 1. Known bleeding diathesis 2. Insulin dependent diabetes mellitus 3. Known personal or family history of keloid formation or scar hypertrophy 4. Known allergy to cyanoacrylate compounds or formaldehyde
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Time for closure of wound 2. Early and late complications 3. Patients and physician's assessment of cosmetic appearance of the healed wound 4. Cost effectiveness | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed